# Levothyroxine Sodium

NDC: 51655-483
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20201123

FDA application: ANDA209713

## Active ingredients

- LEVOTHYROXINE SODIUM: .088 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-483"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-483
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9cb3417-e8cb-13f8-e053-2a95a90a294b